Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR)
SABR offers a valuable treatment option for oligometastatic RCC, demonstrating significant potential for achieving long-term disease control and delaying the need for systemic therapy.
Authors
- Luca Dominici (ORCID: https://orcid.org/0000-0002-3063-5336)
- Carmela Galdieri (ORCID: https://orcid.org/0000-0003-3293-2737)
- Stefano Tomatis (ORCID: https://orcid.org/0000-0002-4791-0373)
- Davide Franceschini (ORCID: https://orcid.org/0000-0003-1142-2439)
- Beatrice Marini (ORCID: https://orcid.org/0000-0002-1375-515X)
- Raffaella LUCCHINI (ORCID: https://orcid.org/0000-0001-9767-8050)
- Anna Bertolini (ORCID: https://orcid.org/0000-0002-1460-8143)
- Tiziana Comito (ORCID: https://orcid.org/0000-0002-5667-0535)
- Luciana Di Cristina
- Veronica Vernier
- Sara Stefanini
- Pietro Mancosu (ORCID: https://orcid.org/0000-0002-0165-7931)
- Ruggero Spoto (ORCID: https://orcid.org/0000-0003-4223-8925)
- Ciro Franzese (ORCID: https://orcid.org/0000-0001-6893-6284)
- Marco Badalamenti (ORCID: https://orcid.org/0000-0001-9004-9614)
- Marta Scorsetti (ORCID: https://orcid.org/0000-0003-0320-559X)
- Maryia Ilieva
Institutions
- Humanitas University (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Cancers
- Published
- 2024-08-25
- DOI
- https://doi.org/10.3390/cancers16172963
- Citations
- 3
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.26